Katherine A High - Net Worth and Insider Trading
Katherine A High Net Worth
The estimated net worth of Katherine A High is at least $24 Million dollars as of 2025-04-28. Katherine A High is the See Remarks of Spark Therapeutics Inc and owns about 210,000 shares of Spark Therapeutics Inc (ONCE) stock worth over $24 Million. Details can be seen in Katherine A High's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Katherine A High has not made any transactions after 2017-11-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Katherine A High
Katherine A High Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Katherine A High owns 3 companies in total, including CRISPR Therapeutics AG (CRSP) , Incyte Corp (INCY) , and Spark Therapeutics Inc (ONCE) .
Click here to see the complete history of Katherine A High’s form 4 insider trades.
Insider Ownership Summary of Katherine A High
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
CRSP | CRISPR Therapeutics AG | 2019-06-11 | director |
INCY | Incyte Corp | 2020-03-26 | director |
ONCE | Spark Therapeutics Inc | 2019-12-17 | director & See Remarks |
Katherine A High Latest Holdings Summary
Katherine A High currently owns a total of 1 stock. Katherine A High owns 210,000 shares of Spark Therapeutics Inc (ONCE) as of November 28, 2017, with a value of $24 Million.
Latest Holdings of Katherine A High
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ONCE | Spark Therapeutics Inc | 2017-11-28 | 210,000 | 113.57 | 23,849,700 |
Holding Weightings of Katherine A High
Katherine A High Form 4 Trading Tracker
According to the SEC Form 4 filings, Katherine A High has made a total of 0 transactions in Spark Therapeutics Inc (ONCE) over the past 5 years. The most-recent trade in Spark Therapeutics Inc is the sale of 5,000 shares on November 28, 2017, which brought Katherine A High around $356,600.
Insider Trading History of Katherine A High
- 1
Katherine A High Trading Performance
Katherine A High Ownership Network
Ownership Network List of Katherine A High
Ownership Network Relation of Katherine A High

Katherine A High Owned Company Details
What does CRISPR Therapeutics AG do?
Who are the key executives at CRISPR Therapeutics AG?
Katherine A High is the director of CRISPR Therapeutics AG. Other key executives at CRISPR Therapeutics AG include Chief Financial Officer Raju Prasad , Chief Business Officer Samarth Kulkarni , and General Counsel and Secretary James R. Kasinger .
CRISPR Therapeutics AG (CRSP) Insider Trades Summary
Over the past 18 months, Katherine A High made no insider transaction in CRISPR Therapeutics AG (CRSP). Other recent insider transactions involving CRISPR Therapeutics AG (CRSP) include a net sale of 261,024 shares made by Samarth Kulkarni , a net sale of 25,642 shares made by James R. Kasinger , and a net sale of 6,801 shares made by .
In summary, during the past 3 months, insiders sold 89,481 shares of CRISPR Therapeutics AG (CRSP) in total and bought 7,000 shares, with a net sale of 82,481 shares. During the past 18 months, 302,950 shares of CRISPR Therapeutics AG (CRSP) were sold and 7,000 shares were bought by its insiders, resulting in a net sale of 295,950 shares.
CRISPR Therapeutics AG (CRSP)'s detailed insider trading history can be found in Insider Trading Tracker table.
CRISPR Therapeutics AG Insider Transactions
Katherine A High Mailing Address
Above is the net worth, insider trading, and ownership report for Katherine A High. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Katherine A High's mailing address is: Philadelphia Pa 19104.